Phase II study of irinotecan, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as first-line therapy
about
Irinotecan, continuous 5-fluorouracil, and low dose of leucovorin (modified FOLFIRI) as first line of therapy in recurrent or metastatic colorectal cancer.Responsiveness of CPT-11 in respect to hMLH1 and hMSH2 protein expression in the primary colorectal cancer.A phase II study of irinotecan, 5-fluorouracil and leucovorin for treatment in patients with previously untreated advanced colorectal cancer.
P2860
Phase II study of irinotecan, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as first-line therapy
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Phase II study of irinotecan, ...... l cancer as first-line therapy
@ast
Phase II study of irinotecan, ...... l cancer as first-line therapy
@en
type
label
Phase II study of irinotecan, ...... l cancer as first-line therapy
@ast
Phase II study of irinotecan, ...... l cancer as first-line therapy
@en
prefLabel
Phase II study of irinotecan, ...... l cancer as first-line therapy
@ast
Phase II study of irinotecan, ...... l cancer as first-line therapy
@en
P2093
P2860
P1476
Phase II study of irinotecan, ...... l cancer as first-line therapy
@en
P2093
Ho-Yong Park
Il-Young Choi
In-Soon Kim
Jung-Hye Choi
Myung-Ju Ahn
Young-Hyo Lim
Young-Woong Won
Young-Yeul Lee
P2860
P304
P356
10.4143/CRT.2004.36.4.235
P577
2004-08-31T00:00:00Z